- Report
- August 2025
- 193 Pages
Global
From €3125EUR$3,545USD£2,745GBP
€3473EUR$3,939USD£3,050GBP
- Report
- March 2025
- 200 Pages
Global
From €2195EUR$2,490USD£1,928GBP
- Report
- August 2025
- 200 Pages
Global
From €2195EUR$2,490USD£1,928GBP
- Report
- May 2025
- 200 Pages
Global
From €2195EUR$2,490USD£1,928GBP
- Report
- May 2025
- 200 Pages
Global
From €2195EUR$2,490USD£1,928GBP
- Report
- March 2025
- 200 Pages
Global
From €2195EUR$2,490USD£1,928GBP
- Report
- April 2025
- 175 Pages
Global
From €3958EUR$4,490USD£3,477GBP
- Report
- January 2025
- 185 Pages
Global
From €3967EUR$4,500USD£3,485GBP
- Report
- August 2025
- 192 Pages
Global
From €3125EUR$3,545USD£2,745GBP
€3473EUR$3,939USD£3,050GBP
- Report
- November 2025
- 198 Pages
Global
From €3125EUR$3,545USD£2,745GBP
€3473EUR$3,939USD£3,050GBP
- Report
- October 2025
- 180 Pages
Global
From €3125EUR$3,545USD£2,745GBP
€3473EUR$3,939USD£3,050GBP
- Report
- October 2025
- 196 Pages
Global
From €3125EUR$3,545USD£2,745GBP
€3473EUR$3,939USD£3,050GBP
- Report
- October 2025
- 192 Pages
Global
From €3125EUR$3,545USD£2,745GBP
€3473EUR$3,939USD£3,050GBP
- Report
- October 2025
- 182 Pages
Global
From €3125EUR$3,545USD£2,745GBP
€3473EUR$3,939USD£3,050GBP
- Report
- August 2025
- 186 Pages
Global
From €3125EUR$3,545USD£2,745GBP
€3473EUR$3,939USD£3,050GBP
- Report
- August 2025
- 182 Pages
Global
From €3125EUR$3,545USD£2,745GBP
€3473EUR$3,939USD£3,050GBP
- Report
- August 2025
- 199 Pages
Global
From €3125EUR$3,545USD£2,745GBP
€3473EUR$3,939USD£3,050GBP
- Report
- August 2025
- 189 Pages
Global
From €3125EUR$3,545USD£2,745GBP
€3473EUR$3,939USD£3,050GBP
- Report
- August 2025
- 194 Pages
Global
From €3125EUR$3,545USD£2,745GBP
€3473EUR$3,939USD£3,050GBP
- Report
- August 2025
- 197 Pages
Global
From €3125EUR$3,545USD£2,745GBP
€3473EUR$3,939USD£3,050GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more